Abstract

Protein phosphorylation is a crucial regulatory mechanism that controls many aspects of cellular signaling. Casein kinase 2 (CK2), a constitutively expressed and active kinase, plays key roles in an array of cellular events including transcription and translation, ribosome biogenesis, cell cycle progression, and apoptosis. CK2 is implicated in cancerous transformation and is a therapeutic target in anti-cancer therapy. The specific and selective CK2 ATP competitive inhibitor, CX-4945 (silmitaseratib), is currently in phase 2 clinical trials. While many substrates and interactors of CK2 have been identified, less is known about CK2 substrates in mitosis. In the present work, we utilize CX-4945 and quantitative phosphoproteomics to inhibit CK2 activity in mitotically arrested HeLa cells and determine candidate CK2 substrates. We identify 330 phosphorylation sites on 202 proteins as significantly decreased in abundance upon inhibition of CK2 activity. Motif analysis of decreased sites reveals a linear kinase motif with aspartic and glutamic amino acids downstream of the phosphorylated residues, which is consistent with known substrate preferences for CK2. To validate specific candidate CK2 substrates, we perform in vitro kinase assays using purified components. Furthermore, we identified CK2 interacting proteins by affinity purification-mass spectrometry (AP-MS). To investigate the biological processes regulated by CK2 in mitosis, we perform network analysis and identify an enrichment of proteins involved in chromosome condensation, chromatin organization, and RNA processing. We demonstrate that overexpression of CK2 in HeLa cells affects proper chromosome condensation. Previously, we found that phosphoprotein phosphatase 6 (PP6), but not phosphoprotein phosphatase 2A (PP2A), opposes CK2 phosphorylation of the condensin I complex, which is essential for chromosome condensation. Here, we extend this observation and demonstrate that PP6 opposition of CK2 is a more general cellular regulatory mechanism.

Highlights

  • Cells traversing mitosis undergo extraordinary changes in organization in order to divide genetic material and organelles between two daughter cells

  • We have shown that Casein kinase 2 (CK2) phosphorylates serine 973/serine 975 on the condensin I subunit NCAPG resulting in its inactivation and that phosphatase 6 (PP6) opposes CK2 on these sites, resulting in condensin I dephosphorylation and activation at the beginning of mitosis (Rusin et al, 2015)

  • Using the selective CK2 inhibitor CX-4945 and quantitative mass spectrometry-based phosphoprotemics, we identify 330 phosphorylation sites on 202 proteins as candidate CK2 substrates (Supplementary Table 1)

Read more

Summary

Introduction

Cells traversing mitosis undergo extraordinary changes in organization in order to divide genetic material and organelles between two daughter cells. In part, these changes are regulated by reversible phosphorylation by kinases and phosphatases. The majority of protein phosphorylation in mitosis has been attributed to master mitotic regulators, such as CDK1, Plk, and Aurora A/B (Salaun et al, 2008), more recently roles for Casein kinase 2 (CK2) in the regulation of cell cycle transitions and mitosis have emerged (Takemoto et al, 2006; Yde et al, 2008; St-Denis et al, 2009, 2011; Li et al, 2010; Barrett et al, 2011; Peng et al, 2011)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call